The anti-cancer mechanisms reported to be associated with TLR-8-mediated activation of mDC include promoting the activation of tumor-specific CD8+ T cells, skewing CD4+ T cell responses towards Th1 [27], and inhibiting Treg function [27]. This evidence concerns the gene TLR8 and cancer.